» Articles » PMID: 33986449

Regulation of Mammalian 3D Genome Organization and Histone H3K9 Dimethylation by H3K9 Methyltransferases

Overview
Journal Commun Biol
Specialty Biology
Date 2021 May 14
PMID 33986449
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Histone H3 lysine 9 dimethylation (H3K9me2) is a highly conserved silencing epigenetic mark. Chromatin marked with H3K9me2 forms large domains in mammalian cells and overlaps well with lamina-associated domains and the B compartment defined by Hi-C. However, the role of H3K9me2 in 3-dimensional (3D) genome organization remains unclear. Here, we investigated genome-wide H3K9me2 distribution, transcriptome, and 3D genome organization in mouse embryonic stem cells following the inhibition or depletion of H3K9 methyltransferases (MTases): G9a, GLP, SETDB1, SUV39H1, and SUV39H2. We show that H3K9me2 is regulated by all five MTases; however, H3K9me2 and transcription in the A and B compartments are regulated by different MTases. H3K9me2 in the A compartments is primarily regulated by G9a/GLP and SETDB1, while H3K9me2 in the B compartments is regulated by all five MTases. Furthermore, decreased H3K9me2 correlates with changes to more active compartmental state that accompanied transcriptional activation. Thus, H3K9me2 contributes to inactive compartment setting.

Citing Articles

Coordinated repression of totipotency-associated gene loci by histone methyltransferase EHMT2 through binding to LINE-1 regulatory elements.

Chatterjee K, Uyehara C, Kasliwal K, Madhuranath S, Scourzic L, Polyzos A bioRxiv. 2025; .

PMID: 39763795 PMC: 11702699. DOI: 10.1101/2024.12.18.629181.


Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation.

Yi Y, Wang G, Zhang W, Yu S, Fei J, An T Nat Commun. 2025; 16(1):212.

PMID: 39747079 PMC: 11695821. DOI: 10.1038/s41467-024-55768-9.


Chromatin protein complexes involved in gene repression in lamina-associated domains.

Manzo S, Mazouzi A, Leemans C, van Schaik T, Neyazi N, van Ruiten M EMBO J. 2024; 43(21):5260-5287.

PMID: 39322756 PMC: 11535540. DOI: 10.1038/s44318-024-00214-1.


Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome.

Wang S, Cheng Y, Lim J, Jang M, Forrest E, Kim Y Res Sq. 2024; .

PMID: 39011107 PMC: 11247926. DOI: 10.21203/rs.3.rs-4530649/v1.


An atlas of the tomato epigenome reveals that KRYPTONITE shapes TAD-like boundaries through the control of H3K9ac distribution.

An J, Brik Chaouche R, Pereyra-Bistrain L, Zalzale H, Wang Q, Huang Y Proc Natl Acad Sci U S A. 2024; 121(28):e2400737121.

PMID: 38968127 PMC: 11252963. DOI: 10.1073/pnas.2400737121.


References
1.
Hayashi-Takanaka Y, Yamagata K, Wakayama T, Stasevich T, Kainuma T, Tsurimoto T . Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. Nucleic Acids Res. 2011; 39(15):6475-88. PMC: 3159477. DOI: 10.1093/nar/gkr343. View

2.
Kadota M, Nishimura O, Miura H, Tanaka K, Hiratani I, Kuraku S . Multifaceted Hi-C benchmarking: what makes a difference in chromosome-scale genome scaffolding?. Gigascience. 2020; 9(1). PMC: 6952475. DOI: 10.1093/gigascience/giz158. View

3.
Nakayama J, Rice J, Strahl B, Allis C, Grewal S . Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science. 2001; 292(5514):110-3. DOI: 10.1126/science.1060118. View

4.
Tachibana M, Sugimoto K, Fukushima T, Shinkai Y . Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem. 2001; 276(27):25309-17. DOI: 10.1074/jbc.M101914200. View

5.
Tzelepis K, Koike-Yusa H, De Braekeleer E, Li Y, Metzakopian E, Dovey O . A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia. Cell Rep. 2016; 17(4):1193-1205. PMC: 5081405. DOI: 10.1016/j.celrep.2016.09.079. View